SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
MRI scans of the brain
Parkinson’s disease
Amneal Wins FDA Approval for Extended-Release Oral Parkinson’s Drug
Crexont was previously rejected by the regulator in June 2023, citing insufficient safety data. However, Amneal Pharmaceuticals’ resubmission included findings from a healthy volunteer study.
August 8, 2024
 · 
2 min read
 · 
Tristan Manalac
Entrance to Vertex's office in Boston, Massachusetts
Government
Vertex Reaches Reimbursement Deal with UK for Casgevy Gene Therapy in Thalassemia
Patients in the U.K. with transfusion-dependent beta-thalassemia will have access to Vertex Pharmaceuticals’ gene editing therapy Casgevy, thanks to an agreement with the National Health Service on the price.
August 8, 2024
 · 
2 min read
 · 
Tristan Manalac
Illustration showing job candidate profiles of two men and one woman
Career Advice
Companies Increasingly Demand Specialized Skill Sets
Employers have adjusted to higher salaries. That also means they’ve become adamant they get specific skill sets, according to Greg Clouse, BioSpace recruitment manager.
August 8, 2024
 · 
3 min read
 · 
Angela Gabriel
Aerial skyline of Austin
Job Trends
9 Life Sciences Companies Hiring in Texas
Looking for a job in Texas? Check out these nine companies hiring life sciences professionals like you.
August 8, 2024
 · 
1 min read
 · 
Angela Gabriel
Novo Nordisk headquarters in Silicon Valley
Earnings
Novo Lowers Full-Year Profit Guidance Amid Disappointing Q2 Semaglutide Sales
Novo Nordisk’s semaglutide brands Ozempic and Wegovy fell short of analyst expectations in the second quarter, mainly held back by supply headwinds. The company’s shares dropped more than 7% in Wednesday morning trading.
August 7, 2024
 · 
2 min read
 · 
Tristan Manalac
Novo Nordisk's corporate headquarters in Denmark
Supply chain
Novo Nearly Catches Up to Lilly, Clears Ozempic and Wegovy from FDA Drug Shortage List
A day after Eli Lilly’s obesity and weight-loss therapies were removed from the regulator’s database, Novo Nordisk also made strides in boosting the supply of all but one of semaglutide’s shortages.
August 7, 2024
 · 
2 min read
 · 
Tristan Manalac
Exeternal view of the Servier's headquarters in France
Approvals
Servier Gets FDA Approval for First Targeted Therapy for Grade 2 IDH-Mutant Glioma
Servier Pharmaceuticals’ vorasidenib on Tuesday secured the FDA’s green light for the treatment of patients with grade 2 gliomas carrying mutations in the IDH gene.
August 7, 2024
 · 
2 min read
 · 
Tristan Manalac
Amgen sign at its headquarters in Thousand Oaks, California, USA.
Earnings
Amgen Touts Q2 Growth Bolstered by Horizon Buy, Promising Obesity Pipeline
The company is projecting that future growth will be driven by geographic and label expansions for its rare disease assets, as well as potential approvals in obesity.
August 7, 2024
 · 
2 min read
 · 
Tristan Manalac
Merck & Co. headquarters in Silicon Valley; Merck & Co. Inc. is an American multinational pharmaceutical company
Vaccines
Gardasil Chinese Distribution Issue Still a Mystery to Analysts
After Merck noted the issue in its Q2 earnings call without providing specifics, analysts are left in the dark about the HPV vaccine’s future in China.
August 7, 2024
 · 
3 min read
 · 
Tyler Patchen
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS